Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label Trial Evaluating the Efficacy of Lacticaseibacillus Paracasei PS23 on Cognition

NCT07168824 is registered in ClinicalTrials.gov with Chi-Chang Huang as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07168824 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label Trial Evaluating the Efficacy of Lacticaseibacillus Paracasei PS23 on Cognition
Lead sponsor
Chi-Chang Huang
Phase
Not applicable
Overall status
Completed
Start date
October 17, 2025
Completion date
April 2, 2026
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

subjective cognitive decline (scd)